TY - JOUR
T1 - Convenient method to purify hemoglobin
AU - Sakai, Hiromi
AU - Takeoka, Shinji
AU - Nishide, Hiroyuki
AU - Tsuchida, Eishun
N1 - Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1994/1
Y1 - 1994/1
N2 - A convenient method to purify Hb solution from outdated RBC has been established for the starting material of Hb-based blood substitutes. To prevent MetHb formation during the procedure, Hb in RBC was carbonylated in advance. Then RBC was mixed with organic solvent for hemolysis and centrifuged for removal of stroma. The resulting SFHb solution was heated at 60C and generated precipitates were removed out by centrifugation. The purity of Hb (25 g/dl) was confirmed by SDS-PAGE. IEF and oxygen binding property of the Hb solution also guaranteed its purity and no denaturation of Hb. This method is applicable to large scale production of the purified Hb for the starting material of Hb-based blood substitutes.
AB - A convenient method to purify Hb solution from outdated RBC has been established for the starting material of Hb-based blood substitutes. To prevent MetHb formation during the procedure, Hb in RBC was carbonylated in advance. Then RBC was mixed with organic solvent for hemolysis and centrifuged for removal of stroma. The resulting SFHb solution was heated at 60C and generated precipitates were removed out by centrifugation. The purity of Hb (25 g/dl) was confirmed by SDS-PAGE. IEF and oxygen binding property of the Hb solution also guaranteed its purity and no denaturation of Hb. This method is applicable to large scale production of the purified Hb for the starting material of Hb-based blood substitutes.
UR - http://www.scopus.com/inward/record.url?scp=0027998630&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027998630&partnerID=8YFLogxK
U2 - 10.3109/10731199409117895
DO - 10.3109/10731199409117895
M3 - Article
C2 - 7994386
AN - SCOPUS:0027998630
SN - 2169-1401
VL - 22
SP - 651
EP - 656
JO - Artificial Cells, Nanomedicine and Biotechnology
JF - Artificial Cells, Nanomedicine and Biotechnology
IS - 3
ER -